These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19740705)

  • 1. The role of resistin as a regulator of inflammation: Implications for various human pathologies.
    Filková M; Haluzík M; Gay S; Senolt L
    Clin Immunol; 2009 Nov; 133(2):157-70. PubMed ID: 19740705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of resistin in obesity-induced insulin resistance.
    Haluzik M; Haluzikova D
    Curr Opin Investig Drugs; 2006 Apr; 7(4):306-11. PubMed ID: 16625816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current biology of resistin.
    Steppan CM; Lazar MA
    J Intern Med; 2004 Apr; 255(4):439-47. PubMed ID: 15049878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistin- and Obesity-associated metabolic diseases.
    Lazar MA
    Horm Metab Res; 2007 Oct; 39(10):710-6. PubMed ID: 17952831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Kouroumalis EA
    Mol Nutr Food Res; 2008 Aug; 52(8):855-66. PubMed ID: 18383234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of resistin in inflammation and inflammation-related diseases.
    Pang SS; Le YY
    Cell Mol Immunol; 2006 Feb; 3(1):29-34. PubMed ID: 16549046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin.
    Cohen G; Hörl WH
    Semin Dial; 2009; 22(4):373-7. PubMed ID: 19708984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin.
    McTernan PG; Kusminski CM; Kumar S
    Curr Opin Lipidol; 2006 Apr; 17(2):170-5. PubMed ID: 16531754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives.
    Dalamaga M
    Biomark Med; 2014; 8(1):107-18. PubMed ID: 24325232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of resistin in obesity, insulin resistance and Type II diabetes.
    Kusminski CM; McTernan PG; Kumar S
    Clin Sci (Lond); 2005 Sep; 109(3):243-56. PubMed ID: 16104844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines as emerging mediators of immune response and inflammation.
    Lago F; Dieguez C; Gómez-Reino J; Gualillo O
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):716-24. PubMed ID: 18037931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.
    Ferrante AW
    J Intern Med; 2007 Oct; 262(4):408-14. PubMed ID: 17875176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory process of adipose tissue.
    Blüher M
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):24-31. PubMed ID: 18806722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adiposity as a determinant of an inflammatory milieu.
    Calabrò P; Limongelli G; Pacileo G; Di Salvo G; Golino P; Calabrò R
    J Cardiovasc Med (Hagerstown); 2008 May; 9(5):450-60. PubMed ID: 18403996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin: functional roles and therapeutic considerations for cardiovascular disease.
    Jamaluddin MS; Weakley SM; Yao Q; Chen C
    Br J Pharmacol; 2012 Feb; 165(3):622-32. PubMed ID: 21545576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines in liver diseases.
    Marra F; Bertolani C
    Hepatology; 2009 Sep; 50(3):957-69. PubMed ID: 19585655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance.
    Tabata M; Kadomatsu T; Fukuhara S; Miyata K; Ito Y; Endo M; Urano T; Zhu HJ; Tsukano H; Tazume H; Kaikita K; Miyashita K; Iwawaki T; Shimabukuro M; Sakaguchi K; Ito T; Nakagata N; Yamada T; Katagiri H; Kasuga M; Ando Y; Ogawa H; Mochizuki N; Itoh H; Suda T; Oike Y
    Cell Metab; 2009 Sep; 10(3):178-88. PubMed ID: 19723494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistin: another rising biomarker in inflammatory bowel disease?
    Karmiris K; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1035-7. PubMed ID: 17998823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin: insulin resistance to malignancy.
    Codoñer-Franch P; Alonso-Iglesias E
    Clin Chim Acta; 2015 Jan; 438():46-54. PubMed ID: 25128719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: The role of adipose tissue in uraemia-related insulin resistance.
    Manolescu B; Stoian I; Atanasiu V; Busu C; Lupescu O
    Nephrology (Carlton); 2008 Oct; 13(7):622-8. PubMed ID: 18826486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.